Venture capital fund invests in PEEK implant company — 3 things to know

Written by Shayna Korol | July 19, 2018 | Print  |

Medical device venture capital fund cultivate(MD) invested into Happe Spine.

Here are three things to know:

1. Happe Spine developed and will commercialize a technology to reinforce PEEK implants based on the work of Ryan K. Roeder, PhD, and University of Notre Dame (Ind.) researchers.

2. The company's spinal interbody implants use hydroxyapatite whisker reinforced PEEK with variable porosity to promote osteointegration.

3. Happe Spine is an early stage portfolio company of Genesis Innovation Group.

More articles on surface technology:

Study says: Nanosurface implant texture increases blood vessel formation, drives bone growth

K2M receives clearances for Cayman United Plate System, enhances 3D-printed lateral cage—3 insights

3 things to know about Tyber Medical 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months